Observed arrival · 2026-09-15
Verilox Puts Quality Control Beside the Point-of-Care Test
Verilox supplies bulk, blood-based control materials for CRP and glucose point-of-care testing devices.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
Field notes
The site describes two ready-to-use control lines: a human serum or blood CRP control and a blood-based glucose control, each offered at levels intended to cover clinically relevant ranges. Verilox says it adjusts filling volume, target values, and analyte combinations to the customer's assay rather than selling a fixed catalogue item. Its release process includes random-vial homogeneity checks against ISO 13528, triplicate stability measurements, and an accelerated one-week comparison at 37 °C.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
One card from the complete issue